The Company historically provided stock-based awards through the 2013 Omnibus Incentive Plan, which provided for awards of restricted stock, restricted stock units, stock options, stock appreciation rights and cash awards to directors, directors emeritus, officers, employees and advisory directors. On November 14, 2022, at the Company's annual meeting, stockholders approved the 2022 Omnibus Incentive Plan which

provides for the same types of awards as described under the 2013 Omnibus Incentive Plan. Going forward, any future grants will be made under this plan.

The cost of equity-based awards under the 2022 Omnibus Incentive Plan generally is based on the fair value of the awards on their grant date. The maximum number of shares that may be utilized for awards under the plan is 1,000,000. Shares of common stock issued under the plan will be issued out of authorized but unissued shares, some or all of which may be repurchased shares.

The table below presents share-based compensation expense and the estimated related tax benefit for stock options and restricted stock for the periods indicated:


	Three Months Ended June 30,				Six Months Ended June 30,
	2026		2025		2026		2025
Share-based compensation expense	$	713	$	496	$	1,480	$	986
Tax benefit	164		117		340		233


	Options	Weighted-Average Exercise Price		Remaining Contractual Life (Years)	Aggregate Intrinsic Value
Options outstanding at December 31, 2024	413,637	$	26.02	3.8	$	3,169


Exercised	(13,700)	24.08
Forfeited	(1,400)	26.72

Options outstanding at June 30, 2025	398,537	$	26.08	3.3	$	4,514
Exercisable at June 30, 2025	373,157	$	25.93	3.1	$	4,285
Non-vested at June 30, 2025	25,380	$	28.37	6.4	$	230

Options outstanding at December 31, 2025	354,797	$	26.19	2.8	$	5,945

Exercised	(125,920)	25.61
Forfeited	(210)	31.35

Options outstanding at June 30, 2026	228,667	$	26.50	2.6	$	5,349
Exercisable at June 30, 2026	219,587	$	26.34	2.5	$	5,171
Non-vested at June 30, 2026	9,080	$	30.34	5.7	$	178

At June 30, 2026, the Company had $48 of unrecognized compensation expense related to 9,080 stock options originally scheduled to vest over a five-year period. The weighted average period over which compensation cost related to non-vested awards is expected to be recognized was 0.6 years at June 30, 2026. At June 30, 2025, the Company had $156 of unrecognized compensation expense related to 25,380 stock options originally scheduled to vest over a five-year period. The weighted average period over which compensation cost related to non-vested awards is expected to be recognized was 0.9 years at June 30, 2025.


	Restricted Stock Awards(1)	Performance-Based Restricted Stock Units(2)	Weighted- Average Grant Date Fair Value		Aggregate Intrinsic Value
Non-vested at December 31, 2024	138,582	30,001	$	27.15	$	5,678
Granted	59,329	15,444	37.38
Vested	(50,326)	—	27.20
Forfeited	(3,621)	—	26.90
Non-vested at June 30, 2025	143,964	45,445	$	31.18	$	7,086

Non-vested at December 31, 2025	144,964	31,341	$	31.52	$	7,571
Granted	61,047	26,034	44.21
Vested	(49,745)	—	30.98
Forfeited	(3,458)	—	34.59
Non-vested at June 30, 2026	152,808	57,375	$	36.86	$	10,486

(1)Restricted stock awards granted in calendar year 2026 are scheduled to vest over 1.0 year for director awards and 3.0 years for employee awards. All restricted stock awards granted prior to calendar year 2026 are scheduled to vest over 1.0 year for director awards and 5.0 years for employee awards.

At June 30, 2026, unrecognized compensation expense was $6,308 related to 210,183 shares of restricted stock. The weighted average period over which compensation cost related to non-vested awards is expected to be recognized was 1.7 years at June 30, 2026. At June 30, 2025, unrecognized compensation expense was $4,803 related to 189,409 shares of restricted stock. The weighted average period over which compensation cost related to non-vested awards is expected to be recognized was 1.8 years at June 30, 2025.